Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AZN - Fidelity Freedom 2030 Fund Q4 2024 Review


AZN - Fidelity Freedom 2030 Fund Q4 2024 Review

2025-03-17 20:49:00 ET

Summary

  • The fourth quarter of 2024 was volatile for most asset classes against a backdrop of the U.S. election, surging dollar strength, sticky inflation and rising interest rates in some markets.
  • Active asset allocation decisions detracted from the Fund's performance versus the Fidelity Freedom® 2030 Composite Index in Q4, whereas the investment performance of the underlying portfolios contributed.
  • The Fund's glide path and strategic asset allocation reflect our long-term views and insights on participant needs, diversification and capital markets.

Performance Summary

Cumulative
Annualized
3
1
3
5
10 Year/ LOF1
Month
YTD
Year
Year
Year
Fidelity Freedom 2030 Fund Gross Expense Ratio: 0.65%2
-2.93%
9.23%
9.23%
1.53%
6.16%
7.04%
S&P 500 Index
2.41%
25.02%
25.02%
8.94%
14.53%
13.10%
Fidelity Freedom 2030 Composite Index
-2.34%
9.69%
9.69%
1.71%
6.00%
7.07%
Morningstar Fund Target-Date 2030
-2.09%
9.46%
9.46%
1.67%
5.93%
6.43%
% Rank in Morningstar Category (1% = Best)
--
--
66%
63%
43%
14%
# of Funds in Morningstar Category
--
--
209
197
171
112

For further details see:

Fidelity Freedom 2030 Fund Q4 2024 Review

Stock Information

Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NASDAQ
Website: astrazeneca.com

Menu

Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...